Age: 27
Free Agency: 2024 (Void)
Accrued Seasons: 6
  • 2022 Salary Cap Charge: $3,882,353 (1.81% of cap)
  • 2022 Cash Payout: $8,500,000 (4.32% of spending)
  • 2022 Cash to Cap Ratio: 2.19
  • Contract Value: $17,000,000 ($8,500,000 APY)
  • Fully Guaranteed Money: $8,500,000
  • Contract Ranking: 22/237 at IDL

Current Contract

(UFA, signed 2022)
(📝: indicates contract trigger occuring during that year)
YearAgeBase SalaryProrated BonusPer Game Roster BonusGuaranteed SalaryCap
Number
Cap %
Dead Money & Cap Savings
202227$1,500,000$1,500,000$1,000,000$1,500,000$3,882,3531.8%
202328$7,250,000$1,500,000$1,250,000$1,000,000$10,000,0004.4%
2024 📝
February 25: Contract voids
29Void$1,500,000VoidVoid$3,000,0001.2%
202530Void$1,500,000VoidVoid$0--
Total$8,750,000$6,000,000$2,250,000$2,500,000$16,882,353

Contract Notes

Maliek Collins signed a two year contract with the Houston Texans on March 15, 2022. Contract value is $17 million with $8.5 million guaranteed. The 2024/2025 contract years void on the 23rd day preceding the 2024 league year.

Cash Flows

- fully earned money
- unearned or partially earned money
$8.5M
$17M
20222023
Cash Due$8,500,000$8,500,000
Running Cash$8,500,000$17,000,000
Career Earnings: $21,914,829
Career APY: $3,652,472
Potential Earnings: $32,914,829
Total Guarantees: $17,131,152
Largest Cash Payment: $8,500,000 (2022)
Largest Cap Number: $10,000,000 (2023)

Contract History

TeamContract TypeStatusYear SignedYrsTotalAPYGuaranteesAmount Earned% EarnedEffective APY
CowboysDraftedExpired20164$3,550,180$887,545$881,152$4,723,652133.1%$1,180,913
RaidersUFAExpired20201$6,000,000$6,000,000$5,750,000$6,000,000100.0%$6,000,000
TexansUFAExpired20211$5,000,000$5,000,000$2,000,000$5,191,177103.8%$5,191,177
TexansUFAActive20222$17,000,000$8,500,000$8,500,000$6,000,00035.3%$0
Earnings By Team
TeamYrsSalaryAPYPaid on Cap% Paid on CapPaid as Dead Money% Paid as Dead Money
Cowboys4$4,723,652$1,180,913$4,723,6520.0%$00.0%
Raiders1$6,000,000$6,000,000$6,250,0000.0%$00.0%
Texans1$11,191,177$11,191,177$4,941,1760.0%$00.0%

Season History

YearTeamBase SalaryProrated BonusPer Game Roster BonusOther BonusGuaranteed SalaryCap
Number
Cap %Cash Paid
2016Cowboys$450,000$220,288$0$0$0$670,2880.4%$1,331,152
2017Cowboys$612,500$220,288$0$0$0$832,7880.5%$612,500
2018Cowboys$755,000$220,288$0$0$0$975,2880.5%$755,000
2019Cowboys$2,025,000$220,288$0$0$0$2,245,2881.1%$2,025,000
2020Raiders$5,750,000$0$250,000$250,000$5,750,000$6,250,0002.8%$6,000,000
2021Texans$2,000,000$2,000,000$1,000,000$0$0$4,941,1762.5%$5,191,177
2022Texans$1,500,000$1,500,000$1,000,000$0$1,500,000$3,882,3531.8%$8,500,000
2023Texans$7,250,000$1,500,000$1,250,000$0$1,000,000$10,000,0004.4%$8,500,000
2024Texans$0$1,500,000$0$0$0$3,000,0001.2%$0
2025Texans$0$1,500,000$0$0$0$0--$0
Total$20,342,500$8,881,152$3,500,000$250,000$8,250,000$32,797,181$32,914,829

Statistics

YearGames PlayedGames InactiveSnapsTacklesNegative PlaysInterceptionsFumblesTD
InjuredHealthyDefenseSpecialSoloAssistSacksYardsTFLQB HitsPass Def.INTYardsForcedRec.Yards
2016160062.8%13.6%1765365130001100
2017160065.6%13.9%1010212480000260
2018133048.3%10.3%127324580000100
2019160071.2%17.3%1554326100000100
2020121046.2%12.3%8700010000000
2021150154.8%17.0%18102.522971100100
202230055.9%14.9%3300111000000

Valuation Diamond

The diamond is a scatterplot graph that visualizes the relation of the player's APY (in green) and performance (in blue, as measured by OTC's Valuations) to the rest of the league at his position. To understand how to read the diamond, read this explainer.

OTC ValuationAPY
Regular$3,177,000$8,500,000
Injury Adjusted$3,177,000$8,500,000
test
OTC Valuation $3.3M $6.5M $9.8M $13M $16.3M APY $5.3M $10.6M $15.8M $21.1M $26.4M $5,096,000 $5,517,500

Weekly Valuation Trends

The chart below illustrates the trend of the player's weekly OTC Valuations (in blue) from the most recent season, using APY (in green) and, if applicable, cash that is due to the player in the next season (in red) as benchmarks. Weeks not plotted indicate that the player was inactive or on a bye.

To see interactive and more in-depth use of OTC Valuation data, subscribe to OTC Premium.